Universal Display Corp. 10-Q Summary: Q1 2010
Business Context and Reporting Period
This is a Quarterly Report (Form 10-Q) for Universal Display Corporation for the period ended March 31, 2010. The Company is engaged in the research, development, and commercialization of organic light emitting diode (OLED) technologies and materials. Its primary strategy involves licensing proprietary technologies to product manufacturers and selling OLED materials.
Key Financial Metrics
| Metric | Q1 2010 | Q1 2009 |
|---|---|---|
| Total Revenue | $4,246,650 | $2,833,858 |
| Net Loss | $(2,978,331) | $(5,569,599) |
| Net Loss Per Share (Basic/Diluted) | $(0.08) | $(0.15) |
| Operating Loss | $(4,224,332) | $(5,993,598) |
| Cash and Cash Equivalents | $7,553,643 | $6,064,487 |
| Short-Term Investments | $55,467,352 | $41,172,955 |
| Total Liquidity (Cash + Investments) | $63,020,995 | $47,237,442 |
| Accumulated Deficit | $(200,087,036) | $(197,108,705) |
| Net Cash Used in Operating Activities | $(442,848) | $(4,505,171) |
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased by $1.41 million (50%) compared to Q1 2009. This was driven by a $461,010 increase in commercial revenue (primarily royalties from Samsung SMD and license fees from Showa Denko) and a $951,782 increase in developmental revenue (driven by development chemical sales and government contract research).
- Expense Reduction: Operating expenses decreased by $356,474. Research and Development (R&D) expenses dropped by $752,431, largely due to decreased costs under agreements with PPG Industries and sponsored research agreements, partially offset by increased employee costs.
- Non-Operating Items: The Company recorded a non-cash gain of $713,243 on stock warrant liability (compared to $173,242 in Q1 2009) and an income tax benefit of $464,162 from the sale of state-related net operating losses and R&D tax credits.
- Liquidity: While cash and cash equivalents decreased from $22.7 million to $7.6 million, total liquidity increased due to a significant rise in short-term investments.
Outlook, Risks, and Contingencies
- Liquidity Outlook: Management anticipates sufficient cash and short-term investments to meet obligations for at least the next 12 months. However, additional funding may be required in the future for R&D and commercialization, with no assurance of availability.
- Legal Proceedings: The Company is involved in several patent oppositions and invalidation trials:
- EP '958 (FOLED): CDT appealed an EPO decision upholding the patent; the Company expects to file a reply by August 12, 2010.
- EP '238 (PHOLED): Oppositions filed by Sumation, Merck, and BASF are pending oral hearing dates.
- JP '929 (PHOLED): Semiconductor Energy Laboratory filed an invalidation trial; response due July 15, 2010.
- EP '270 (PHOLED): Five European companies (including Merck, BASF, Osram, Siemens, Philips) filed oppositions in April 2010.
- Concentration Risk: Two non-government customers accounted for 48% of revenue in Q1 2010. All chemical materials are purchased from a single supplier (PPG Industries).
- Unusual Items: The Company adopted a Supplemental Executive Retirement Plan (SERP) effective April 1, 2010, which will result in a non-current liability and accumulated other comprehensive loss estimated at approximately $5.6 million.
Key Facts for Investor Verification
- Verify the sustainability of the 50% revenue growth, specifically the reliance on two customers representing 48% of revenue.
- Monitor the outcomes of the multiple pending international patent oppositions (EP '958, EP '238, EP '270, JP '929) which are critical to the Company's licensing model.
- Assess the impact of the new $5.6 million liability associated with the Supplemental Executive Retirement Plan on future financial statements.
- Review the Company's cash burn rate; while operating cash outflow improved significantly to $0.44 million, the Company remains in an accumulated deficit of over $200 million.
- Confirm the valuation assumptions for the stock warrant liability, which generated a significant non-cash gain of $0.71 million.